Retinal pericytes inhibit activated T cell proliferation.

Area of Science:

• Immunology
• Ophthalmology
• Cell Biology

Background:

• Diabetic retinopathy (DR) is a leading cause of vision loss.
• The role of retinal pericytes (RPCs) in DR pathogenesis is not fully understood.
• RPCs may possess immunomodulatory functions relevant to retinal health.

Purpose of the Study:

• To investigate the immunosuppressive capacity of RPCs.
• To determine if hyperglycemia impairs RPC function.
• To elucidate the role of RPCs in protecting retinal endothelial cells (RECs) from inflammation.

Main Methods:

• RPCs were assessed for their ability to inhibit T cell proliferation and cytokine production.
• Mechanisms of inhibition, including PD-L1 and IL-10, were investigated using blocking antibodies.
• RPCs' protective effects on RECs against apoptosis were evaluated.
• The impact of high glucose and methylglyoxal (MGO) on RPC immunosuppressive activity was tested.

Main Results:

• RPCs demonstrated potent inhibition of T cell proliferation and inflammatory cytokine production.
• RPCs express PD-L1 and produce IL-10, contributing to their immunosuppressive activity.
• RPCs significantly reduced inflammation-induced apoptosis in RECs.
• High glucose and MGO significantly reduced the T cell inhibitory activity of RPCs.

Conclusions:

• RPCs are highly immunosuppressive and protect RECs from inflammation-mediated apoptosis.
• Hyperglycemic conditions impair the immunosuppressive function of RPCs.
• This impaired RPC function represents a novel mechanism contributing to diabetic retinopathy development.